You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)攜手杏脈科技設立新公司 提供影像診斷技術等服務
格隆匯 05-31 20:04

格隆匯5月31日丨復星醫藥(02196.HK)公吿,2021年5月31日,公司控股子公司禪城醫院與關聯方杏脈科技簽訂《合資合同》,擬共同投資設立新公司(以下簡稱“本次投資”)。新公司的註冊資為人民幣500萬元,其中:禪城醫院、杏脈科技擬分別以人民幣250萬元的現金出資認繳新公司註冊資的50%。

新公司擬藉助雙方股東現有技術和醫療資源的優勢,通過遠程閲片、影像專家遠程會診等方式,為各類醫療機構提供包括“遠程影像、實時診斷”功能在內的各項解決方案,同時也為影像診斷技術條件和資源相對匱乏的基層醫療機構診療水平的提升提供支持和服務。禪城醫院將以自籌資金支付本次投資的對價。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account